Skip to main content
Back to News
ChemLex has secured $45M and launched its self-driving lab in Singapore, dramatically accelerating A...
Funding
1 min read
SG

ChemLex has secured $45M and launched its self-driving lab in Singapore, dramatically accelerating A...

The AMW Read

This is an incremental update regarding a new player in the AI-driven drug discovery space; it does not meet the $500M threshold for cross.§D.
NoveltySignificance
Healthcare & Bio · Player Map

ChemLex has secured $45M and launched its self-driving lab in Singapore, dramatically accelerating AI-driven drug discovery. This move positions Singapore as a key hub for deep tech and biomedical innovation. With a market projected to reach nearly $50B by 2034, AI's impact on pharmaceutical R&D is rapidly transforming the industry, compressing discovery timelines from months to weeks.

#AIDiscovery #DrugDevelopment #Singapore #LifeSciences #AIforScience

How This Connects

Based on Healthcare & Bio · Player Map

  1. 3d agoInnovaccer acquires CaduceusHealth to expand AI-led revenue cycle managementInnovaccer
  2. 1w agoIsomorphic Labs raises $2.1B led by Thrive Capital in largest AI drug-discovery roundIsomorphic Labs
  3. 3w agoOpenAI model outperforms doctors in ER diagnoses, achieving 67% accuracy vs 55%OpenAI
  4. 1mo agoOpenAI Launches GPT-Rosalind, a Specialized Frontier Model for Life Sciences Research and Drug DiscoveryOpenAI
  5. 5mo agoChemLex has secured $45M and launched its self-driving lab in Singapore, dramatically accelerating A... · THIS ARTICLE

Related News

More news from ChemLex

Stay updated with the latest news and announcements from ChemLex.

View all ChemLex news

Discover AI Startups

Explore 2,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard